- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC in the Press, October 7, 2016
Highlights of our peer-reviewed research in the healthcare and mainstream press.
In Friday’s Morning eHealth daily report, POLITICO’s Darius Tahir discussed HIPAA in the age of cloud computing and mentioned a recent study in The American Journal of Managed Care (AJMC) that proposed expanding state prescription drug monitoring programs. The authors suggest expanding these programs to all prescription drugs, instead of just opiates.
Aledade’s report providing an inside look at the accountable care organizations (ACOs) the company has helped start continues to receive attention. As part of a Q&A with Aledade’s Farzad Mostashari, MD, Healthcare Informatics’ Rajiv Leventhal noted the report Mostashari co-wrote for AJMC and how the authors looked at ways CMS could prove the Medicare ACO programs.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
